These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 26621891

  • 1. Linezolid in drug-resistant tuberculosis: haste makes waste.
    Bhuniya S, Mohapatra PR, Panigrahi MK, Behera P, Pradhan G.
    Eur Respir J; 2015 Dec; 46(6):1843-4. PubMed ID: 26621891
    [No Abstract] [Full Text] [Related]

  • 2. Linezolid in drug-resistant tuberculosis: haste makes waste.
    Hughes J, Isaakidis P, Andries A, Mansoor H, Cox V, Meintjes G, Cox H.
    Eur Respir J; 2015 Dec; 46(6):1844-6. PubMed ID: 26621892
    [No Abstract] [Full Text] [Related]

  • 3. Linezolid for multidrug-resistant tuberculosis in HIV-infected and -uninfected patients.
    Hughes J, Isaakidis P, Andries A, Mansoor H, Cox V, Meintjes G, Cox H.
    Eur Respir J; 2015 Jul; 46(1):271-4. PubMed ID: 25837033
    [No Abstract] [Full Text] [Related]

  • 4. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
    Rose PC, Hallbauer UM, Seddon JA, Hesseling AC, Schaaf HS.
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
    [Abstract] [Full Text] [Related]

  • 5. Dried blood spots can help decrease the burden on patients dually infected with multidrug-resistant tuberculosis and HIV.
    Zuur MA, Akkerman OW, Touw DJ, van der Werf TS, Cobelens F, Burger DM, Grobusch MP, Alffenaar JW.
    Eur Respir J; 2016 Sep; 48(3):932-4. PubMed ID: 27288037
    [No Abstract] [Full Text] [Related]

  • 6. Haematological adverse effects associated with linezolid in patients with drug-resistant tuberculosis: an exploratory study.
    Letswee G, Kamau H, Gaida R, Truter I.
    Int J Pharm Pract; 2019 Dec; 27(6):575-577. PubMed ID: 31058394
    [Abstract] [Full Text] [Related]

  • 7. Multidrug-resistant tuberculosis in an HIV-infected girl.
    Shah I, Mohanty S.
    Natl Med J India; 2012 Dec; 25(4):210-1. PubMed ID: 23278778
    [Abstract] [Full Text] [Related]

  • 8. Multidrug-resistant tuberculosis and the need for biosocial perspectives.
    Farmer P, Bayona J, Becerra M.
    Int J Tuberc Lung Dis; 2001 Oct; 5(10):885-6. PubMed ID: 11605879
    [No Abstract] [Full Text] [Related]

  • 9. Linezolid-Resistant Enterococcus faecalis Infection Following Prolonged Low-Dosage Linezolid Treatment for Multidrug-Resistant Tuberculosis.
    Baccani I, Antonelli A, Galano A, Bartalesi F, Bartoloni A, Rossolini GM.
    Clin Infect Dis; 2017 Nov 29; 65(12):2159-2160. PubMed ID: 29020204
    [No Abstract] [Full Text] [Related]

  • 10. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Sotgiu G, Lange C, Richardson MD, Matteelli A, Centis R, Eker B, Guenther G, Spanevello A, Migliori GB, TBNET.
    J Antimicrob Chemother; 2009 Oct 29; 64(4):879-83; author reply 883-4. PubMed ID: 19651787
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of multidrug-resistant tuberculosis using therapeutic drug monitoring: first experiences with sub-300 mg linezolid dosages using in-house made capsules.
    Bolhuis MS, van der Werf TS, Kerstjens HAM, de Lange WCM, Alffenaar JC, Akkerman OW.
    Eur Respir J; 2019 Dec 29; 54(6):. PubMed ID: 31439686
    [No Abstract] [Full Text] [Related]

  • 12. Reversal of misfortunes.
    Cohen J.
    Science; 2013 Feb 22; 339(6122):898-903. PubMed ID: 23430629
    [No Abstract] [Full Text] [Related]

  • 13. Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index.
    Wasserman S, Meintjes G, Maartens G.
    Expert Rev Anti Infect Ther; 2016 Oct 22; 14(10):901-15. PubMed ID: 27532292
    [Abstract] [Full Text] [Related]

  • 14. Immune reconstitution syndrome following initiation of antiretroviral therapy in a patient with HIV infection and multidrug-resistant tuberculosis.
    Swaminathan S, Padmapriyadarsini C, Narendran G, Thomas BE, Anand S, Rajyalakshmi A.
    Indian J Chest Dis Allied Sci; 2005 Oct 22; 47(4):299-304. PubMed ID: 16255403
    [Abstract] [Full Text] [Related]

  • 15. Linezolid Induced Reversible Peripheral Neuropathy.
    Vishnu VY, Modi M, Goyal MK, Lal V.
    Am J Ther; 2016 Oct 22; 23(6):e1839-e1841. PubMed ID: 26741956
    [Abstract] [Full Text] [Related]

  • 16. [Adverse drug reactions in multidrug-resistant tuberculosis].
    Palmero D, Cruz V, Museli T, Pavlovsky H, Fernández J, Waisman J.
    Medicina (B Aires); 2010 Oct 22; 70(5):427-33. PubMed ID: 20920959
    [Abstract] [Full Text] [Related]

  • 17. Highlights of a year in AIDS.
    Laurence J.
    AIDS Read; 2007 Mar 22; 17(3):107-9, 120. PubMed ID: 17396328
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tuberculosis drug resistance and HIV infection, the Netherlands.
    Haar CH, Cobelens FG, Kalisvaart NA, van der Have JJ, van Gerven PJ, van Soolingen D.
    Emerg Infect Dis; 2007 May 22; 13(5):776-8. PubMed ID: 17553264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.